QuickView for L-phenylalanine:pyruvate aminotransferase activity (biogroup)

1. L1000 CMAP - Colorectal cancer DLD-1 cells with shRNA-mediated gene knockdown
2. L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
3. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
4. Mouse primary hepatocyte gene expression after stimulation with IL-1beta, IL-17 or TNF-alpha
5. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens

There were no matches for L-phenylalanine:pyruvate aminotransferase activity

1. Brentuximab Vedotin and Gemcitabine Hydrochloride in Treating Younger Patients With Relapsed or Refr…
2. Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity …
3. Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning…
4. A Study to Give Treatment Inside the Eye to Treat Retinoblastoma
5. Autologous Peripheral Blood Stem Cell Transplant for Neurologic Autoimmune Diseases